Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramez N Eskander

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Epigenetic Landscape in the Treatment of Gynecologic MalignanciesRamez N Eskander
Med (New York, N.Y.)|April 15, 2021
Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignanciesRamez N Eskander, Razelle Kurzrock
Surgical Oncology Clinics of North America|February 24, 2024
Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative RisksDaisuke Nishizaki, Ramez N Eskander
Female Pelvic Medicine & Reconstructive Surgery|May 29, 2019
Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?Tatiana Catanzarite, Ramez N Eskander
Recent Patents on Anti-Cancer Drug Discovery|December 6, 2017
PARP Inhibitors in Epithelial Ovarian CancerKristin N Taylor, Ramez N Eskander
Journal of Gynecologic Oncology|July 22, 2014
Beyond angiogenesis blockade: targeted therapy for advanced cervical cancerRamez N Eskander, Krishnansu S Tewari
Future Oncology (London, England)|March 12, 2015
Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicologyRamez N Eskander, Krishnansu S Tewari
Therapeutic Advances in Medical Oncology|April 2, 2021
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trialsRamez N Eskander, Matthew A Powell
Gynecologic Oncology|December 10, 2013
Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implicationsRamez N Eskander, Krishnansu S Tewari
Gynecologic Oncology Research and Practice|May 28, 2016
Immunotherapy in endometrial cancer - an evolving therapeutic paradigmTeresa C Longoria, Ramez N Eskander
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
The Epigenetic Landscape in the Treatment of Gynecologic MalignanciesRamez N Eskander
Med (New York, N.Y.)|April 15, 2021
Maternal to fetal transmission of cancer: implications for molecular tumor testing, immune regulation, and pediatric malignanciesRamez N Eskander, Razelle Kurzrock
Surgical Oncology Clinics of North America|February 24, 2024
Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative RisksDaisuke Nishizaki, Ramez N Eskander
Female Pelvic Medicine & Reconstructive Surgery|May 29, 2019
Opportunistic Salpingectomy at the Time of Urogynecologic Surgery: Why, in Whom, and How?Tatiana Catanzarite, Ramez N Eskander
Recent Patents on Anti-Cancer Drug Discovery|December 6, 2017
PARP Inhibitors in Epithelial Ovarian CancerKristin N Taylor, Ramez N Eskander
Journal of Gynecologic Oncology|July 22, 2014
Beyond angiogenesis blockade: targeted therapy for advanced cervical cancerRamez N Eskander, Krishnansu S Tewari
Future Oncology (London, England)|March 12, 2015
Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicologyRamez N Eskander, Krishnansu S Tewari
Therapeutic Advances in Medical Oncology|April 2, 2021
Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trialsRamez N Eskander, Matthew A Powell
Gynecologic Oncology|December 10, 2013
Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implicationsRamez N Eskander, Krishnansu S Tewari
Gynecologic Oncology Research and Practice|May 28, 2016
Immunotherapy in endometrial cancer - an evolving therapeutic paradigmTeresa C Longoria, Ramez N Eskander
Pageof 10